Share on StockTwits

Hologic (NASDAQ:HOLX) was downgraded by equities research analysts at Standpoint Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports.

Hologic (NASDAQ:HOLX) traded down 0.81% on Wednesday, hitting $25.59. 2,627,491 shares of the company’s stock traded hands. Hologic has a one year low of $18.46 and a one year high of $26.18. The stock has a 50-day moving average of $24.6 and a 200-day moving average of $22.50. The company’s market cap is $7.071 billion.

Hologic (NASDAQ:HOLX) last announced its earnings results on Wednesday, April 30th. The company reported $0.37 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.33 by $0.04. The company had revenue of $625.00 million for the quarter, compared to the consensus estimate of $609.35 million. On average, analysts predict that Hologic will post $1.40 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on HOLX. Analysts at Zacks reiterated a “neutral” rating on shares of Hologic in a research note on Wednesday, June 25th. They now have a $26.00 price target on the stock. Separately, analysts at Needham & Company LLC raised their price target on shares of Hologic from $26.00 to $30.00 in a research note on Wednesday, June 25th. They now have a “buy” rating on the stock. Finally, analysts at Argus raised their price target on shares of Hologic from $27.00 to $31.00 in a research note on Monday, May 12th. They now have a “buy” rating on the stock. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $23.83.

Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.